The Heliothis armigera entomopoxvirus (HaEPV) genome encodes a predicted 68 kDa polypeptide related to the 'rifampicin resistance' protein of vaccinia virus (with 30 % identity), and an homologous swinepox virus protein (27 % identity). We were unable to isolate an HaEPV genotypic variant encoding a predicted Cterminal truncated form of the protein, suggesting that the C terminus of the molecule may be essential to protein function, and, in turn, that this function may be essential to viral replication. HaEPV replication was substantially reduced in host cells exposed to rifampicin, but the observed cytotoxic properties of the drug made it impossible to determine the specific cause of that inhibition. We suggest that possession of a gene encoding a member of this polypeptide family might represent a defining molecular characteristic of the Poxviridae.
Introduction
The Poxviridae is divided at sub-family level into the chordopoxviruses (ChPVs) and entomopoxviruses (EPVs), whose members are, respectively, restricted to vertebrate and insect hosts (Murphy et aL, 1995) . EPVs display a variety of characteristics which differentiate them from ChPVs (Goodwin et al., 1991) , and which probably reflect their specific and long-standing association with caterpillar, grasshopper, beetle and other insect hosts. Despite these differences, a number of shared physical, biochemical and morphogenic characters unify the poxvirus sub-families (Moss, 1990) , and suggest the probable existence of parallel homologies at a molecular level.
Sequences of EPV genes encoding metabolic enzymes such as DNA polymerase, thymidine kinase and nucleoside triphosphohydrolase (Mustafa & Yuen, 1991; Gruidl et al., 1992; Lytvyn et al., 1992; Yuen et al., 1991) are available, and provide clear evidence of the relationship between the poxvirus sub-families (Arif, 1995) . Nonetheless, because homologues of these same genesalbeit more distantly related -are used by other doublestranded DNA viruses of apparently unrelated lineages, they cannot be considered to constitute definitive evidence for the presumed single origin of all members of * Author for correspondence. Fax +61 6 246 4173. e-mail davidd@ento.csiro.au
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the Poxviridae. Indeed, strongest proof of that hypothesis would derive from the description of a series of gene homolognes unique to, but widely distributed within, the family, and preferably encoding proteins with functions related to processes or structures highly conserved between, and peculiar to, all known poxviruses.
We describe here one such candidate gene which, in the context of the vaccinia virus (VV) homologue (D 13L; Johnson et al., 1993) , encodes a protein known variously as VV p65, L65 or rifampicin resistance factor (Sodiek et al., 1994 , Vanslyke & Hruby, 1994 Johnson et al., 1993) . That protein has been reported to play an essential role in formation of the crescent-shaped membranous structures which constitute an early and distinctive stage of vaccinia virion formation (Sodiek et al., 1994) . Morphological correlates of those structures have consistently been reported from cells infected with ChPVs and EPVs (Moss, 1990; Granados, 1981) , including, specifically, in vivo and in vitro infections of Heliothis armigera EPV (HaEPV; Goodwin et al., 1991; Lai-Fook et al., 1994) . Homologues of the gene have been reported from variola and swinepox viruses (Massung et al., 1993 (Massung et al., , 1994 , and its presence in the Amsacta moorei EPV (AmEPV) genome has long been inferred, and recently confirmed (Granados, 1981; Winter et aL, 1995) . We report here the sequence of an homologue, termed the 68K gene, from the HaEPV genome, present evidence consistent with the hypothesis that the encoded 68 kDa (' 68K') polypeptide is essential for HaEPV replication, and describe the effect of rifampicin on insect cell survival and HaEPV replication. R.J. Osborne and others
Methods

Virus and cells. Methods for in vivo maintenance of HaEPV in
Helicoverpa armigera larvae and isolation of virus have been described (Dall et al., 1993) . Identical methods were employed here; larvae of both H. armigera (Ha) and Chrysodeixis argentifera (Ca; Lep., Noctuidae), a species previously recorded as susceptible to infection (Teakle, 1990) , were used for in vivo HaEPV propagation. Techniques associated with in vitro propagation of HaEPV in Helicoverpa zea cells [BCIRL-Hz-AM1 (Hz-AM1); McIntosh & Ignoffo, 1981] or their derivatives, and Spodopterafrugiperda cells (Sf9; ATCC CRL 1711) are described elsewhere (Fernon et al., 1995) . Unless otherwise noted, in vitro infections used a mixed population of HaEPV originating from Ha-derived virus (Fernon et al., 1995) , and propagated in Hz-AM1 cells. Specifically identified isolates of HaEPV were prepared in Hz-AM 1 cells by infection with limiting dilutions of the mixed population virus, further sequential passage at limiting dilution, and subsequent amplification.
HaEPV released into in vitro culture medium by infected cells was used as one source of genomic DNA for PCR amplification. Virion DNA was prepared by addition of proteinase K (200 gg/ml in 10 mMTris, pH 8"0, 5 mM-EDTA, 0.25% SDS, final concentrations) to collected medium, followed by incubation for 6 h at 37 °C, boiling for 10 min, and dilution with 6-5 vols of autoclaved purified (Millipore) water. PCR amplifications (see below) used 2-5 lal of these preparations as template.
Nucleic acid manipulation. Methods for preparation and selection of cloned HaEPV genomic DNA have been described (Dall et al., 1993) . Oligonucleotides (oligos) used in sequencing and PCR protocols were custom synthesized in-house, or by DNagency; descriptions of oligos used for PCR are provided in Table 1 . Sequence data presented here were obtained by sequencing both strands of relevant parts of cloned BglII (clone 36; 4.9 kb), XbaI (clone 6; 2.9 kb) and EcoRV (clone $32; a 1.8 kb incomplete portion from the 5' end of a 3 kb fragment)-digested HaEPV DNA, and three cloned copies of a PCR product generated with oligos 3 and 5, as shown in Fig. 1 (a) .
RT-PCR studies used total RNA isolated from mock-and HaEPVinfected Sf9 cells by the method of Chomczynski & Sacchi (1987) ; 10-15 lag of total cellular RNA was heated at 95 °C for 5 min, cooled to 60 °C prior to addition of 7 U of RNase-free DNase, incubated at 37 °C for 30 rain, then phenol extracted and precipitated, cDNA synthesis reactions (25 ~tl) contained 1 lag of prepared RNA as template, 4 U of avian myoblastosis virus and 100 U of Moloney muriue leukaemia virus reverse transcriptases (RTs), 1 mM-dNTPs and 4 mMoligo (final concentrations), and were incubated for 90 min at 37 °C. Mock cDNA synthesis reactions contained 25 U of RNase instead of RTs; in each case 10 lal of the synthesis reaction was used as template for PCR amplification.
All PCR amplifications used 4-6 U of Taq DNA polymerase in 100 lal reaction volumes containing 1"5 mM-MgC12, 50 mM-KC1, 10 mMTris, pH 8.3 and 0'1% gelatin (final concentrations). RT PCR used a 5 rain pre-incubation at 80 °C prior to addition of polymerase, then 25 cycles of 94 °C for 1 min, 55 °C for 1 rain and 72 °C for 2 rain. PCR amplification from cloned and genomic double-stranded DNA used a 94 °C, 5 min pre-incubation, 5 cycles of 45 °C for 1.5 min, 72 °C for 1.5 min and 94 °C for 1 rain, then 30 more cycles identical except for increase of annealing temperature to 50 °C. PCR amplicons were typically cloned into pTZ19R or similar vectors for further analysis, and sequenced by standard dideoxy protocols. Analysis of sequence data used the Wisconsin GCG package (Devereux et al., 1984) in conjunction with GenBank Release 84, and BLAST-based searches of GenBank.
Rifampicin studies. Crystalline rifampicin (Sigma) was resuspended in TC199MK medium (Mclntosh et al., 1973) at 500 gg/ml and stored at 4 °C until use. Cell lines from S. frugiperda (SO), Trichoplusia ni (TN-CL1; McIntosh & Rechtoris, 1974) , Plutella xylostella (BCIRLPx2-HNV3; Chen et al., 1983; McIntosh & Ignoffo, 1989) , and four clonal lines derived from Hz-AM1 (2F3, 3B5, 2B2 and 2El0; Fernon et al., 1995) were tested for ability to tolerate the drug. Maintenance of all lines has been described (Fernon et al., 1995) ; tolerance was assessed by estimation of growth rates in media containing 0, 50 or 100 lag rifampicin/ml.
Preliminary investigation of the effect of rifampicin on HaEPV multiplication used Hz-AMl-derived 2El0 (Hz-2E10) and TN-CL1 cells seeded at a density of 1 x 105 cells per well (six-well plate), and infected at an m.o.i, of 2. Media contained 0, 50 or 100~tg rifampicin/ml. Each treatment was established in duplicate; media were harvested 7 days post-infection (p.i.) and their TCIDs0 titres determined (Reed & Muench, 1938) . A subsequent investigation of HaEPV/rifampicin interaction used Hz-2E10 cells selected for growth in progressively increasing concentrations of the drug. The general selection protocol was based on growth of Hz-2E10 cells to confluence in 25 cm 2 flasks and subsequent subculture at 50% confluence level; drug concentration was increased by 10-15 lag/ml per passage. In the experiment reported here a rifampicin level of 25 gg/ml was reached by sequential passages at 10 and 25 lag/ml, followed by several passages at the final concentration. Cells (2x 105) were seeded in flasks, and infected at an m.o.i, of 1 ; following their infection both the selected and non-selected Hz-2E10 cells were grown in medium without added rifampicin. Each treatment was established in triplicate, media were collected 7 days p.i., then titred as above.
Results
Analysis of the HaEPV 68K gene sequence
We sequenced about 2'5 kb of HaEPV genomic DNA immediately 3' of the coding region of the fusolin gene (Dall et at., 1993), contained within partially overlapping BglII, XbaI and EcoRV fragments, or their associated PCR products (Fig. 1 a) . Analysis of that sequence ( Fig.  1 b) showed that the 5' part consisted of a 771 bp A/Trich (82%) region whose longest open reading frame (ORF) in either orientation potentially encoded a 34 Johnson et al., 1993) and swinepox virus (Massung et al., 1993) homologues (VV and SP, respectively). Asterisks show aa's conserved in all sequences; well conserved regions (> 50% identity; see text) are underlined.
to the products of the vaccinia (VV) and variola (VAR) virus D13L and N3L genes, respectively (Johnson et al., 1993; Massung et al., 1994) , and a homologous gene of swinepox virus (SP; Massung et al., 1993) . The deduced HaEPV protein has 30, 30 and 27 % aa identity with those three proteins, respectively; in comparison the VV protein has 70 % identity with its SP homologue. An alignment of aa sequences of the VV, SP and HaEPV proteins (using the GCG GAP algorithm at default settings; Devereux et al., 1984) is shown in Fig.  2. [The VAR aa sequence is essentially ( > 99 %) identical to that of VV (Massung et al., 1994; Shchelkunov et al., 1994) , and is thus not included]. As shown in Fig. 2 , conservation of aa at the termini of the proteins was minimal, with only 6 of 66 residues (to the first HaEPVspecific sequence insertion) and 11 of 79 residues (from the last HaEPV insertion) retained in all N and C termini, respectively. Only the second of two aa residues (VV Q27 and N480) previously recorded as critical to the interaction of rifampicin and the VV protein (Tartaglia & Paoletti, 1985; Baldick & Moss, 1987) was conserved in the deduced HaEPV protein. Homology between the HaEPV and other poxvirus proteins was most evident in two short regions (Fig. 2, underlined) beginning at HaEPV residues 354 and 410, in which 24 of 43 aa (56 %), and 31 of 58 aa (53 %) were conserved.
Southern blot analyses of caterpillar (Ca)-derived HaEPV genomic DNA prepared by single or double digestion with EcoRI, BamHI, HindIII and SacI restriction enzymes were consistent with the presence of a single copy of the gene in the viral genome (not shown).
Analysis of a variant (defective)form of the HaEPV 68K gene
A variant form of the HaEPV gene, apparently encoding a defective product, was also cloned and sequenced during this investigation. The variant was originally recognized in an EcoRV-generated clone ($32) of genomic DNA from caterpillar (Ha)-derived HaEPV, and was subsequently also found in an HaEPV isolate, derived from the same source, being passaged in vitro (see below). Fig. 3 shows the nucleotide and deduced encoded aa sequences of the variant gene in a region flanked by BgIII sites, beginning at the 3' end of the (clone 36) 4-9 kb genomic fragment. The variant sequence was found to contain an 85 bp insertion (lower case), of which the 82, Y bases (underlined) are a direct repeat of the aa-coding nucleotide sequence (upper case, underlined) starting 5 bp 3' of the first BgIII site (bold). The insertion was bounded at its 5' end by a newly created sequence element (bold italics) which differed by only one nucleotide from the BglII recognition sequence, and 3' by a BgIII site (bold). The absence of an internal adenylate residue from the 5' Bg/II-like repeat border predicts a reading frame shift (with respect to the gene encoding the full-length protein) and almost immediate termination of translation at a newly generated TAA codon. The deduced product of this gene is thus predicted
On: Sat, 29 Dec 2018 12:49:22
H a E P V 68K gene
843
A G A T C T A G T A A A T C T A A A A A A A A C G A T A T T T A T A T A G A T G A T C C A T T T G T A T T C G G A
R S S K S K K N D I Y I D D P F V F G
T T A G A C T T T T T A T C T A A A G A A T T G G G T A T A A T A A G t c t a a t c t a a a a a a a a c q a t a t
t t a t a t a a a t a a t c c a t t t q t a t t c q a a t t a Q a c t t t t t a t c t a a a Q a a t t a a Q t a t a a t a a a C A G A T C T to be 468 aa long, and in comparison to the full-length polypeptide, to lack a conserved arginine residue (R-467 becomes L-467 due to the reading frame shift) and the subsequent 117 C-terminal aa residues, and to have acquired residues L-467 and 1-468. The serine residue at the site of the insertion event (S-466) is retained as a consequence of coding degeneracy. Examination of HaEPV stocks maintained by in vitro passage revealed the presence of the variant form of the gene in one virus isolate. As shown in Fig. 4 , PCR amplification from a preparation of caterpillar (Ca)-derived genomic HaEPV DNA, using oligos 3 and 4 (Table 1) , produced a single band consistent in size (250 bp) with that expected from the gene encoding the full-length 68K protein (Fig. 4, lane 1) ; amplification from genomic DNA of an in vitro-maintained HaEPV isolate (wt#2/011293, lane 2) did likewise. In contrast, amplification from a cloned fragment of HaEPV genomic DNA known to contain the repeat element (EcoRV, $32; see above) produced a slightly larger band (335 bp) consistent with the presence of that tandem repeat in the amplicon (lane 4); amplification from DNA of a second virus isolate (wt#1/011293, lane 3) produced bands consistent in size with the presence of both forms of the gene, with an apparent molar excess of the product presumed to contain the repeat element. This interpretation of the identities of amplification products was subsequently confirmed by sequencing cloned copies of each amplicon.
We attempted to separate viruses containing the different forms of the gene observed in isolate wt#1/011293 by further dilution cloning and in vitro expansion. PCR analysis of genomic DNA from 15 replication-competent samples generated from limiting or near limiting dilutions of that isolate showed that only one form of the gene-consistent in size with that determined above as encoding the full-length proteinwas present in each sample. We interpret these results as indicating that viruses which possess the variant form of the gene-and, by inference, produce the truncated encoded protein-are not capable of autonomous replication.
Products of RT-PCR amplifications using oligo pairs 1 and 2, or 1 and 4 (Table 1) , and total RNA prepared from Sf9 cells 48 h after infection with in vitro-maintained mixed population HaEPV, were single bands (not shown). These bands were not observed when amplifications were initiated with mock cDNA synthesis reactions (in which reverse transcriptase was replaced with RNase) from the same template, or when total RNA from mock-infected cells was used as template. The size of each of the products was consistent with that predicted from the sequence encoding the full-length 68K protein, suggesting that the defective copy of the gene was rare in the mixed HaEPV population from which it was isolated.
Effect of rifampicin on insect cells and HaEPV replication
Cell lines derived from T. ni, P. xylostella and S. frugiperda (TN-CL1, BCIRL-Px2-HNV3 and Sf9, respectively), and four Hz-AM1 derived clonal lines were screened for ability to grow in the presence of rifampicin at concentrations of 50 or 100 gg/ml. Multiplication and survival of all lines was severely affected at each concentration. At the lower concentration P. xylostella cells died within 48 h of exposure, but Hz-2E10 cells grew at about half the rate of controls (no rifampicin) for 5 days before beginning to decrease in number; TN-CL1 and Sf9 cells showed similar temporal growth profiles to Hz-2E10 cells, though at reduced relative proportions with respect to controls.
Based on the observation that Hz-2E10 cells appeared to have a degree of innate tolerance to the lower concentration of rifampicin, we attempted adaptation of the line to continuous replication in its presence. Despite various attempts using the 'progressive increase' protocol described in Methods, and drug concentrations of 10-70 gg/ml, we were ultimately unable to establish a permanent rifampicin-adapted line. We were, however, able to stabilize Hz-2E10 cells in rifampicin at 25 gg/ml, and at this concentration as many as nine passages were recorded before loss of the line.
Preliminary investigation of HaEPV replication in Hz-2E10 and TN-CL1 cells grown with rifampicin showed reductions of some 10-50-fold in quantities of infectious virions accumulated in culture media. These experiments, however, used 'naive' cell populations not previously exposed to the drug, and despite choice of host lines on the basis of a degree of innate rifampicin tolerance (see above), it appeared that presence of the drug, even at 50 gg/ml, had an adverse effect on the cells. This experiment thus did not allow effective separation of the drug's potential virus-specific and host-cell related effects on HaEPV replication. In addition, use of an infectivity assay to quantify HaEPV replication was based on the (untested) assumption of unaltered infectivity of budded virions produced in the presence of the drug.
A further investigation thus compared virus replication in 'naive' and 'adapted' (25 lag/ml) Hz-2E10 cells. In this experiment the drug was removed from adapted cells immediately before infection (m.o.i. of 1), and was subsequently omitted from all culture media, allowing assessment of any persistent effects on host cell physiology, and eliminating potential interference with infectivity of budded progeny virions. We found that virus production 7 days p.i. by the previously adapted cells [TCID~0 = 1467 ± 133 infectious particles (i.p.)/ml; mean_+ s~, n = 3] was substantially less than that of cells which had never been exposed to the drug (TCID~0 = 35333+4703 i.p./ml). This suggested that exposure to rifampicin has long-term and detrimental effects on the ability of these host cells to support HaEPV replication, and, as a corollary, that our initial findings could not be interpreted as reflecting drug-induced inhibition of replication. These conclusions were supported by direct observations using electron microscopy; we noted that adapted (25 gg/ml) Hz-2E10 cells were morphologically atypical in comparison with naive cells, showing characteristics such as highly lobed nuclei, and the presence of large numbers of electron-lucent vesicles in peripheral cytoplasm.
Discussion
We have determined the sequence of the gene located immediately 3' of the HaEPV fusolin locus. The deduced encoded 68K polypeptide shows 27-30 % identity with proteins previously described from chordopoxviruses, specifically, the 'rifampicin resistance factor' proteins of the orthopox vaccinia (VV) and variola viruses (Johnson et al., 1993; Massung et al., 1994 ) and a 62K protein of swinepox virus (Massung et al., 1993) . The VV-encoded homologue is involved in one of the earliest stages of virion formation-the virus-induced production of Golgi-derived crescent-shaped membranes (Sodiek et al., 1994) , and the presence of morphologically identical structures in HaEPV-infected cells (Goodwin et al., 1991; Lai-Fook et al., 1994) suggests that the EPVencoded homologue could have a similar function.
Amino acid substitutions in either the N or C termini of the VV-encoded homologue can abolish sensitivity to rifampicin (Tartaglia & Paoletti, 1985; Baldick & Moss, 1987) , and on this basis it has been postulated that normal function involves 'head-to-tail' interaction of molecules of the protein (Baldick & Moss, 1985) . While our results suggest that the C-terminal portion of the HaEPV-encoded polypeptide is essential to function (see below), we have also observed that termini show minimal amino acid conservation between homologues from the two poxvirus sub-families (Fig. 2) . In contrast, we note the existence of two juxtaposed ' internal' regions which are relatively well-conserved (each showing > 50% identity) between homologues. Given that the attributed 'scaffolding' function of this protein probably requires interaction both between the termini and between the molecule and components of host-cell Golgi organelles, these regions might conceivably mediate this latter interaction. This suggestion fits our expectation that conservation of elements of the sub-cellular machinery in eukaryotic hosts would constrain variation in the domain(s) of the protein(s) involved in such processes; in comparison, termini of the molecules are likely to be relatively free to co-evolve.
